Correlation of Mesalamine Pharmacokinetics With Local Availability

Trial Profile

Correlation of Mesalamine Pharmacokinetics With Local Availability

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2017

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Crohn's disease; Diverticulitis; Inflammatory bowel diseases; Ulcerative colitis; Ulcerative proctitis
  • Focus Pharmacokinetics
  • Sponsors University of Michigan
  • Most Recent Events

    • 02 May 2017 Status changed from active, no longer recruiting to completed.
    • 11 May 2016 Planned End Date changed from 1 Sep 2015 to 1 Apr 2017.
    • 10 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top